PLOS Medicine Submission Guide: What to Prepare Before You Submit
PLOS Medicine's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Associate Professor, Clinical Medicine & Public Health
Author context
Specializes in clinical and epidemiological research publishing, with direct experience preparing manuscripts for NEJM, JAMA, BMJ, and The Lancet.
Readiness scan
Before you submit to PLOS Medicine, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
How to approach PLOS Medicine
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Presubmission inquiry (optional but recommended) |
2. Package | Full manuscript preparation |
3. Cover letter | Online submission through Editorial Manager |
4. Final check | Editorial assessment and triage |
Decision cue: A strong PLOS Medicine submission does not just present good clinical research. It demonstrates that the findings matter for clinical practice or health policy in settings beyond a single health system. If the global relevance case is not clear in the abstract, editors will stop early.
Quick answer
PLOS Medicine uses a two-stage submission process. The initial submission is streamlined: submit a manuscript quickly and get rapid editorial feedback on whether the work fits. If editors are interested, they request a full submission with detailed formatting.
The journal is selective (~15% acceptance rate) and screens heavily for global health relevance. Papers about clinical practice, health policy, or epidemiology that matter across health systems and income settings are the strongest fit. Work that is primarily relevant to one country or one health system will struggle unless the implications are explicitly broader.
Before you prepare a submission, confirm these things are true:
- the clinical or public health question has clear relevance beyond one national context
- the study design can support the size of the claims
- the reporting follows the appropriate guideline (CONSORT, STROBE, PRISMA, etc.)
- the data availability plan is concrete and ready
- the manuscript can survive comparison with work published in BMJ or Lancet Global Health
What PLOS Medicine actually screens for
Unlike PLOS ONE, which evaluates soundness, PLOS Medicine evaluates significance. The editorial standard is: will this work directly and substantially inform clinical practice or health policy?
That question breaks into five parts:
What editors check | What they need to see | Common failure |
|---|---|---|
Global health relevance | Findings matter across settings, not just in one health system | Study framed as if one national context is universal |
Clinical or policy impact | Direct implications for practice or policy decisions | Results are scientifically interesting but do not change clinical behavior |
Methodological rigor | Design appropriate for the question, adequate power, proper controls | Good question with underpowered design or uncontrolled confounders |
Reporting completeness | Appropriate checklist fully completed (CONSORT, STROBE, PRISMA) | Generic or incomplete reporting checklist |
Data transparency | Data available or access conditions clearly specified | Vague data availability statement |
The initial submission process
PLOS Medicine's initial submission is designed to give authors fast editorial feedback without requiring full formatting.
What to include in the initial submission
- complete manuscript text with structured abstract (300 words preferred, 500 words maximum)
- author list with CRediT contributions
- ORCID for the corresponding author (required)
- figures and tables (embedded or separate)
- cover letter (optional but strongly recommended)
What you do NOT need for the initial submission
- perfect PLOS formatting
- final supplementary materials
- full data deposit (though you need a plan)
- detailed reference formatting
The point of the initial submission is to get an editorial decision on fit before you invest in full formatting. If editors want the paper, they will request a complete submission with all the details.
Presubmission inquiries
PLOS Medicine does not use a separate presubmission inquiry form. The initial submission IS the presubmission inquiry. Authors who email asking about fit will be directed to submit the manuscript as an initial submission.
What the cover letter should do
The cover letter is optional but valuable at PLOS Medicine. It is your chance to frame the global health relevance and policy implications before editors read the paper.
The cover letter should:
- state the main finding in one or two sentences
- explain the clinical or health policy implication clearly
- describe why the finding matters across health systems, not just in the study setting
- note the study design and why it supports the claims
- mention any prior PLOS interactions about this work
Do not repeat the abstract. Argue for relevance, not summarize the findings.
Reporting guidelines are non-negotiable
PLOS Medicine requires discipline-specific reporting checklists:
- Randomized controlled trials: CONSORT
- Observational studies: STROBE
- Systematic reviews and meta-analyses: PRISMA
- Diagnostic accuracy studies: STARD
- Study protocols: SPIRIT
The checklist must be completed specifically, not generically. Editors can tell when a checklist has been filled in to satisfy a requirement rather than to genuinely document the reporting.
Check the EQUATOR Network if you are not sure which guideline applies.
Each checklist item should reference a specific section, page, or paragraph in your manuscript. A completed CONSORT checklist where every item says "see Methods" is not specific enough. The item for "Allocation concealment mechanism" should point to the exact paragraph describing the concealment method, not just the Methods section in general.
Data availability matters at PLOS
Like all PLOS journals, PLOS Medicine requires a data availability statement. Underlying data should be deposited in a public repository or made available as supplementary material. "Data available upon request" without specific conditions is not sufficient.
For clinical trial data, the journal expects a specific plan: what data will be shared, when, through what mechanism, and under what conditions. PLOS takes this seriously because transparency is central to the journal's mission.
Preferred repositories include Dryad, Figshare, or field-specific options like ClinicalTrials.gov for trial data or the WHO ICTRP for international trials. If the data cannot be fully shared due to patient confidentiality, the statement must explain what is available, what is restricted, and how qualified researchers can request access through a specific process.
Common preparation mistakes
Framing a local study as globally relevant without explaining how
A randomized trial conducted in one hospital is not automatically globally relevant just because the disease is common worldwide. The manuscript needs to explain specifically how the findings translate to other settings: different health systems, different resource levels, different populations. Generic statements about global burden are not enough.
Treating PLOS Medicine like a stronger PLOS ONE
PLOS Medicine and PLOS ONE serve fundamentally different purposes. PLOS ONE evaluates soundness. PLOS Medicine evaluates significance and global health relevance. A paper that is methodologically sound but lacks clear clinical or policy impact will not pass the PLOS Medicine screen.
Submitting without the appropriate reporting checklist
This is one of the most avoidable failures. If the study is a randomized trial without a CONSORT checklist, or an observational study without STROBE, the manuscript will be returned. Complete the correct checklist before submission.
Overclaiming policy implications
A single observational study rarely "demonstrates" that a policy should change. PLOS Medicine editors are experienced enough to recognize when claims outpace the evidence. Match the language to the study design: "suggests," "is consistent with," and "supports the hypothesis" are appropriate for most observational findings.
How to compare PLOS Medicine against nearby alternatives
Feature | PLOS Medicine | BMJ | Lancet Global Health | |
|---|---|---|---|---|
Scope | Global health, clinical practice, health policy | Broad clinical medicine | Broad clinical medicine, international | Global health specifically |
Impact factor | 9.9 | 105 | 88.5 | 17.4 |
Acceptance rate | ~15% | ~7% | <5% | ~10% |
Open access | Yes (PLOS) | Hybrid | Hybrid | Yes (Lancet OA) |
Review speed | 6 to 8 weeks | 4 to 6 weeks | 3 to 4 weeks | 4 to 6 weeks |
Best for | Clinical research with global health relevance | Broad clinical practice studies | Highest-impact clinical trials | Low- and middle-income country focus |
Choose when | The work matters across health systems and is open-access | The audience is primarily clinical practitioners | The consequence is practice-changing at the highest level | The primary audience is global health practitioners |
Submit if
- the study has clear clinical or health policy implications that travel across health systems
- the reporting checklist is complete and specific to the study design
- the data availability plan is concrete
- the manuscript is framed for a global health audience, not a single-country audience
- the work can survive comparison with BMJ, Lancet Global Health, or similar
Think twice if
- the clinical consequence is mainly relevant to one national health system
- the study is mechanistic or translational rather than clinical
- the reporting checklist is incomplete or generic
- the global health framing depends on language rather than evidence
- the manuscript was written for a specialty clinical journal and has not been reframed
Before you submit, check your readiness score with a free scan. It takes about 60 seconds and evaluates methodology, citations, and journal fit.
Sources
On this page
Final step
Submitting to PLOS Medicine?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Submitting to PLOS Medicine?
Anthropic Privacy Partner. Zero-retention manuscript processing.